The mechanism of the inhibitory action of phenidone, 3-amino-1-[m-(trifluoromethyl)phenyl]-2-pyrazoline (BW 755C), dithiothreitol, hydroquinone, and pyrogallol on the vascular relaxation induced by endothelium-derived relaxing factor (EDRF) was investigated. EDRF was released from porcine aortic endothelial cells in culture and bioassayed on a cascade of superfused rabbit aortic strips. These results led us to suggest that superoxide ions (0°-) play a role in the inactivation of EDRF (6). A similar conclusion has been reached by others (7).
from porcine aortic endothelial cells in culture and bioassayed on a cascade of superfused rabbit aortic strips. These compounds inhibited EDRF-induced relaxation of vascular strips, without affecting the relaxation induced by glyceryl trinitrate, and their inhibitory potency was markedly attenuated (by more than 1 order -of magnitude) by the addition of superoxide dismutase (5-15 units/ml) or oxidized cytochrome c (20-40 lAM) but not by catalase (30 units/ml) or heat-inactivated superoxide dismutase. These data indicate that the above five inhibitors inactivate EDRF through the formation of superoxide ions, which have recently been shown to destroy EDRF. The inhibition of EDRF by these compounds is therefore attributable to their redox properties rather than to any specific biological action.
Vascular relaxation induced by a number of pharmacological agents is mediated by a humoral factor, derived from vascular endothelial cells, known as endothelium-derived relaxing factor (EDRF) (1) . Many substances have been identified as inhibitors of EDRF in arterial preparations. These include antioxidants and sulfhydryl reagents, as well as inhibitors of phospholipase, arachidonic acid lipoxygenase, and cytochrome P-450-dependent enzymes (1) (2) (3) (4) . All these compounds have diverse biological activities. However, when used as tools to identify the chemical nature of EDRF, their inhibitory effect has often been ascribed to only one of their known biological actions. Therefore, EDRF has alternatively been suggested to be a product of lipoxygenation of arachidonic acid (3), or a product of its oxygenation by a cytochrome P-450-dependent enzyme (4) These results led us to suggest that superoxide ions (0°-) play a role in the inactivation of EDRF (6) . A similar conclusion has been reached by others (7).
We have now used our bioassay system to study the mechanism of action of some previously identified EDRF inhibitors-namely, phenidone, 3-amino-1-[m-(trifluoromethyl)phenyl]-2-pyrazoline (BW 755C), hydroquinone, and dithiothreitol.
METHODS
Porcine aortic endothelial cells were cultured on microcarriers. The cell column and the bioassay cascade were assembled as described (5) . In brief, a column containing [2] [3] [4] [5] [6] 
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and a microcarrier-stirrer system (Techne, Cambridge, U.K.).
RESULTS
Bradykinin (20 nM t.c.) or ionophore A23187 (0.2-5 gM t.c.)
induced release ofa RbA-relaxing substance from the column of endothelial cells. This substance was identified as EDRF, since it had a half-life of less than 7 sec, its release was not inhibited by indomethacin, and its action was inhibited by hemoglobin and methylene blue (10 and 50 LM o.t., respectively; data not shown). When administered t.c., phenidone, BW 755C, hydroquinone, and dithiothreitol caused a concentration-dependent inhibition of EDRF-induced relaxation ofthe uppermost RbA (Fig. 1 ). All the compounds were less active o.t. than t.c., but the difference between activity o.t. and t.c. was greater for BW 755C and phenidone than for dithiothreitol and hydroquinone ( Fig. 1) . The inhibitory effect of all the compounds, whether administered o.t. or t.c., appeared rapidly (within 10 sec), was promptly reversible, and did not increase when the infusion was prolonged. This could be demonstrated during the protracted release of EDRF induced by A23187 (data from an experiment in which hydroquinone was used are shown in Fig. 2 released EDRF, which survived as far as the fourth RbA in the cascade, and infusion of BW 755C (100 ,uM t.c.) had no effect on the release of EDRF. In the absence of superoxide dismutase, EDRF was less stable (total disappearance by the third RbA) and BW 755C (10 ,uM t.c.) caused a significant inhibition of its action. The tissues were contracted by an infusion of U-46619 (30 LM o.t.) and were approximately equisensitive to relaxation induced by n3Gro (50 nM o.t.). iment in which this compound was administered t.c. is shown in Fig. 4 . Furthermore, the effect of pyrogallol was decreased by more than 1 order of magnitude by superoxide dismutase (Fig. 4) .
When cytochrome c (20-40 uM) was given o.t. in the absence of the column effluent, it had no effect on the assay tissues. However, when given either t.c. or o.t. in the presence of effluent from the column, it induced a. relaxation of the assay tissues that was greater in the uppermost RbA and decreased the further down the cascade the detector tissue was situated. The effect of 40 jLM cytochrome c t.c. 
DISCUSSION
We have used our bioassay system to confirm that hydroquinone, dithiothreitol, phenidone, and BW 755C inhibit vascular relaxation induced by EDRF released by bradykinin and A23187 from porcine aortic endothelial cells in culture. Unlike hemoglobin and methylene blue (9) , these four compounds do not affect the response to n3Gro, indicating that they do not inhibit EDRF-mediated relaxation by inhibition of guanylate cyclase. Therefore, these inhibitors selectively affect EDRF action by some other mechanism, such as inhibition of its synthesis or action or by its accelerated destruction.
Various biochemical properties are usually associated with these compounds. For example, hydroquinone is an aromatic antioxidant that prevents lipid peroxidation (10) , dithiothreitol is a sulfhydryl reagent that reactivates a number of suffhydryl group-containing enzymes (11) , and phenidone (12) and BW 755C (13) are best known as mixed-function lipoxygenase/cyclooxygenase inhibitors. Could such a diversity of biochemical and chemical actions underlie a single effect of these compounds as inhibitors of EDRF?
We have recently shown that superoxide dismutase protects EDRF against inactivation (6) . Since superoxide dismutase is a specific enzymic inactivator of Oi-ions, its effect is generally accepted as evidence for the involvement ofthese ions in a particular system. As a result we examined the effect of superoxide dismutase on the action of these compounds and found that this enzyme significantly attenuates their inhibitory potency. The potency of the compounds was not affected either by heat-inactivated superoxide dismutase or by catalase, indicating that this effect of superoxide dismutase is dependent on its enzymic activity and that Oi-ions and not other oxygen-derived radicals are the active species.
The mechanism of this attenuation is probably not due to Proc. Natl. Acad. Sci. USA 83 (1986) increased amounts of EDRF overcoming the action of the inhibitors, as one would still expect to see an effect of the inhibitors on relaxations smaller than the control. This is not the case. As seen in Fig. 3 , the control relaxation of the top tissue, which is 60-70% of that induced by the standard n3Gro (50 nM), is greatly reduced by 10 ,uM BW 755C, whereas, in the presence of superoxide dismutase, smaller responses in the lower tissues are totally unaffected by a 10-fold greater dose of BW 755C (100 ,uM). This clearly indicates that the effect of superoxide dismutase is not due to a shift of the dose-response curve of EDRF but to an abrogation of the mechanism by which EDRF is destroyed.
This possibility was further examined in experiments with oxidized cytochrome c, another scavenger of O°-ions. Oxidized cytochrome c is readily reduced by O°-ions and is therefore widely used in spectrophotometric methods for their detection (14) . Indeed, we found that cytochrome c has a superoxide dismutase-like effect, since it increases the stability of EDRF, as demonstrated by an increase in the EDRF-induced relaxation of the tissues further down the cascade and the unmasking of its spontaneous release from the endothelial cells. Cytochrome c also attenuated the inhibitory potency of all four compounds studied. While superoxide dismutase achieves this effect by dismuting O°-ions, cytochrome c could be acting either by removing O-f ions or by interacting directly with the active species of these compounds to prevent their reduction of 02 to Of-ions.
From all these observations we predicted that pyrogallol, a potent generator of O-ions in aqueous solutions (15) , should also be an effective inhibitor of EDRF-induced vascular relaxation and that cytochrome c should reduce the inhibitory activity of pyrogallol. We confirmed this in additional experiments in which we also showed that superoxide dismutase markedly attenuated the activity of pyrogallol.
Our data indicate that there is a common mechanism for the inhibitory action of the four compounds investigated, which is also shared by pyrogallol: namely, the generation of O-f ions which in turn inactivate EDRF. Such an action could also explain the inactivation of EDRF by catecholamines (16) , for these compounds can also generate O-ions during their autoxidation (17) . Final confirmation of this mechanism of action is dependent on direct measurement of O-ions. Preliminary experiments using electron-spin resonance (ESR) have failed to show the presence of O-ions; however, the quantity of O-ions likely to be present in our system is below the limit of detection of this method.
All the compounds tested are likely to reduce 02 to Of2 ions either directly or subsequent to their conversion to semiquinones or radical cations (18) (19) (20) . The generation of free radical products and/or Of--derived radicals during autoxidation of high concentrations (20 mM) of these inhibitors has been confirmed by ESR (T. F. Slater, personal communication). A similar activation reaction is reported to underlie the cardiotoxicity of antitumor anthracyclines (21) .
In this instance, the quinone moiety is reduced in microsomes to the semiquinone, which then generates cytotoxic O-ions. All EDRF inhibitors studied may be activated to varying degrees by endothelial cells, leading to the generation of O-f ions by a similar mechanism. Such an effect could account for the greater potency of these compounds t.c. than o.t. Additional support for the proposed mechanism of action comes from the observation that the inhibition of EDRF by these compounds, including pyrogallol, was rapid in onset and promptly reversible, suggesting a direct chemical interaction rather than an enzymic inhibition, which one would expect to be slower in onset and longer-lasting.
The relevance of our findings to the in vivo situation is difficult to assess. It is likely that the potency of these compounds is highly dependent on the local concentration of 02. This could explain why they are less potent in other experimental conditions (1) (2) (3) (4) than in our cascade superfusion where continuously flowing hyperoxic buffer is used. Nevertheless, O-ions are reported to be responsible for the conversion of the acetylcholine-induced cerebral arteriolar dilatation to vasoconstriction during acute experimental hypertension (22) and to participate in the tissue damage induced by postischemic reperfusion in several organs (23) . These effects are prevented by superoxide dismutase (23 
